The Massachusetts Institute of Technology (MIT) has been awarded a $1,589,772 federal Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, effective September 1, 2024 through August 31, 2027, will fund the development of a novel mHealth balance assessment and rehabilitation system for Neurofibromatosis Type 2 (NF2) using computer vision and artificial intelligence technologies. The project aims to transform healthcare for military service members and the general public through innovative medical research. No sub-award details were provided.
Generated 3/4/25, 7:29 AM